| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977207 | Brachytherapy | 2014 | 9 Pages |
Abstract
In men with large prostates, the PSI provides biochemical control and temporal changes in genitourinary toxicity that are comparable with men having smaller glands. Accurate dose optimization and delivery of PSI provides the best clinical outcomes regardless of gland size.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kosj Yamoah, Harriet B. Eldredge-Hindy, Nicholas G. Zaorsky, Joshua D. Palmer, Laura A. Doyle, Jocelyn A. Sendecki, Adam A. Hesney, Logan Harper, Michael Repka, Timothy N. Showalter, Mark D. Hurwitz, Adam P. Dicker, Robert B. Den,